Kyogoku unyu shoji
9073
BlueMeme
4069
Estore
4304
Visumo
303A
D. Western Therapeutics Institute
4576
(FY)Mar 31, 2024 | (FY)Mar 31, 2023 | (FY)Mar 31, 2022 | (FY)Mar 31, 2021 | (FY)Mar 31, 2020 | (FY)Mar 31, 2019 | (FY)Mar 31, 2018 | (Q4)Mar 31, 2018 | (Q3)Dec 31, 2017 | (Q2)Sep 30, 2017 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating cash flow (Indirect Method) | ||||||||||
Cash from operating activities | 114.91%73.94B | -22.48%34.4B | -41.38%44.38B | 62.99%75.71B | -4.88%46.45B | -14.31%48.83B | 2.25%56.99B | 37.42%16.39B | 15.98%15.76B | 30.47%13.78B |
Net profit before non-cash adjustment | 13.70%36.81B | -11.08%32.37B | 63.98%36.41B | 12.14%22.2B | -37.96%19.8B | 2.65%31.91B | 8.34%31.09B | -11.29%7.56B | 48.08%9.51B | 5.09%7.15B |
Total adjustment of non-cash items | 17.88%41.75B | -22.09%35.42B | 9.71%45.45B | 41.96%41.43B | -2.82%29.19B | -5.85%30.03B | 23.39%31.9B | 120.46%10.51B | -25.59%6.17B | 108.30%7B |
-Depreciation and amortization | 3.35%40.78B | 3.96%39.46B | 4.66%37.95B | 5.60%36.26B | 6.81%34.34B | 6.03%32.15B | 9.04%30.32B | 10.08%8.04B | 6.68%7.55B | 9.42%7.43B |
-Reversal of impairment losses recognized in profit and loss | ---- | ---- | 18.06%1.06B | --897M | ---- | ---- | ---- | ---- | ---- | ---- |
-Assets reserve and write-off | ---- | ---- | --2.33B | --0 | ---- | ---- | ---- | ---- | ---- | ---- |
-Share of associates | -29.20%-177M | -3.79%-137M | -21.10%-132M | 27.33%-109M | -417.24%-150M | 80.14%-29M | -23.73%-146M | -113.04%-49M | -50.00%-30M | 7.89%-35M |
-Disposal profit | -1,077.40%-6.53B | 34.14%668M | 1,706.45%498M | 94.60%-31M | 46.36%-574M | -301.51%-1.07B | 135.40%531M | 98.67%-27M | 31.10%274M | -26.20%138M |
-Other non-cash items | 267.85%7.67B | -222.08%-4.57B | -15.10%3.75B | 199.55%4.41B | -335.27%-4.43B | -185.40%-1.02B | 453.71%1.19B | 618.78%2.54B | -257.63%-1.62B | 85.16%-531M |
Changes in working capital | 86.16%-4.62B | 10.93%-33.38B | -410.34%-37.48B | 576.97%12.08B | 80.68%-2.53B | -118.53%-13.11B | -605.22%-6B | -23.05%-1.68B | 107.17%81M | -193.73%-374M |
-Change in receivables | -258.38%-12.45B | 86.43%-3.47B | -10,309.76%-25.61B | -101.86%-246M | 347.64%13.2B | 55.79%-5.33B | -161.51%-12.05B | -77.99%1.55B | 86.10%-1.91B | -624.74%-10.52B |
-Change in inventory | 83.64%-4.07B | 9.68%-24.88B | -411.62%-27.54B | 258.61%8.84B | 43.53%-5.57B | -59.78%-9.87B | -52.27%-6.18B | 64.14%-1B | -14.64%-3.95B | -136.89%-380M |
-Change in payables | 374.02%13.11B | -132.71%-4.79B | 950.86%14.63B | 112.52%1.39B | -7,786.52%-11.12B | -101.65%-141M | 17.32%8.57B | 40.33%-3.74B | -65.87%5.33B | 68,664.29%9.6B |
-Provision for loans, leases and other losses | -386.75%-1.21B | -123.92%-249M | -50.26%1.04B | 117.34%2.09B | -56.87%963M | -39.06%2.23B | 43.74%3.66B | 120.03%1.53B | 32.83%619M | 10.67%923M |
Dividends paid (cash flow from operating activities) | ||||||||||
Dividends received (cash flow from operating activities) | ||||||||||
Interest paid (cash flow from operating activities) | -69.21%-3.31B | -80.18%-1.96B | 18.11%-1.09B | 23.01%-1.33B | 14.34%-1.72B | -19.51%-2.01B | -19.73%-1.68B | -7.80%-553M | -35.95%-329M | -32.93%-545M |
Interest received (cash flow from operating activities) | 5.92%2.06B | 13.10%1.94B | 12.00%1.72B | -14.21%1.53B | -10.52%1.79B | 13.98%2B | -7.98%1.75B | -6.67%350M | 14.01%529M | -57.78%133M |
Tax refund paid | -57.10%-10.77B | 39.96%-6.86B | -226.07%-11.42B | 46.38%-3.5B | 25.45%-6.53B | -19.85%-8.76B | 9.91%-7.31B | -15.45%-1.59B | -3.31%-2.4B | 34.85%-617M |
Other operating cash inflow (outflow) | -100.17%-2M | 129.88%1.18B | -68.47%512M | 81,300.00%1.62B | -100.19%-2M | 1.05B | 0 | 200.00%1M | -200.00%-1M | 150.00%1M |
Operating cash flow | 115.64%61.91B | -15.82%28.71B | -53.94%34.11B | 85.18%74.04B | -2.75%39.98B | -17.36%41.11B | 3.39%49.75B | 40.23%14.6B | 18.02%13.56B | 33.98%12.75B |
Investing cash flow | ||||||||||
Net PPE purchase and sale | -55.07%-61.32B | -5.93%-39.54B | 5.33%-37.33B | 6.68%-39.43B | 0.07%-42.25B | -24.17%-42.28B | 4.44%-34.05B | -2.63%-9.03B | -22.34%-8.91B | 21.78%-7.38B |
Net intangibles purchase and sale | -67.20%-3.95B | 9.15%-2.36B | 12.28%-2.6B | 10.07%-2.97B | -82.26%-3.3B | -28.75%-1.81B | 4.68%-1.41B | 10.81%-429M | -82.13%-428M | 35.14%-216M |
Net business purchase and sale | ---1.13B | --0 | ---336M | --0 | 102.24%37M | -62.82%-1.65B | -894.12%-1.01B | --461M | ---9M | ---- |
Net investment product transactions | 508.50%9.74B | 100.00%1.6B | 819.54%800M | -98.15%87M | 16,657.14%4.69B | 102.28%28M | -181.32%-1.23B | -129.48%-311M | 75.00%-5M | -209.69%-532M |
Advance cash and loans provided to other parties | -971.72%-1.06B | 75.13%-99M | 54.46%-398M | 29.40%-874M | -1.48%-1.24B | -30.76%-1.22B | -197.13%-933M | -171.43%-35M | 29.35%-65M | 76.96%-47M |
Repayment of advance payments to other parties and cash income from loans | -16.07%282M | -46.84%336M | -44.80%632M | 31.31%1.15B | -24.96%872M | 29.83%1.16B | 322.17%895M | 44.00%36M | 203.70%82M | -66.15%44M |
Net changes in other investments | 30.11%-1.33B | -424.24%-1.9B | 69.52%-363M | -91.79%-1.19B | 57.38%-621M | -37.58%-1.46B | -86.77%-1.06B | -112.73%-49M | 4.16%-645M | -115.87%-20M |
Investing cash flow | -40.03%-58.77B | -6.00%-41.97B | 8.41%-39.6B | -3.40%-43.23B | 11.48%-41.81B | -21.74%-47.23B | -6.67%-38.8B | -20.49%-9.35B | -20.59%-9.98B | -4.17%-9.62B |
Financing cash flow | ||||||||||
Net issuance payments of debt | -64.48%10.36B | 360.25%29.16B | 143.84%6.34B | -229.99%-14.45B | 69.00%11.12B | 108.10%6.58B | 221.91%3.16B | 456.86%3.12B | -233.77%-1.34B | 511.81%2.37B |
Net common stock issuance | 65.05%-2.81B | -201,175.00%-8.05B | -33.33%-4M | 25.00%-3M | 99.71%-4M | 35.98%-1.37B | -52.85%-2.14B | 101.90%33M | 13.48%160M | -929.46%-929M |
Increase or decrease of lease financing | -47.16%-1.27B | -39.64%-863M | -23.35%-618M | -105.33%-501M | -92.13%-244M | -273.53%-127M | 80.12%-34M | 36.54%-33M | 639.47%205M | 35.14%-24M |
Cash dividends paid | 6.05%-7.14B | -16.50%-7.6B | 0.00%-6.52B | 4.75%-6.52B | -15.95%-6.85B | 0.46%-5.91B | 6.24%-5.93B | --0 | 1.47%-2.95B | --0 |
Cash dividends for minorities | 1.76%-279M | -22.94%-284M | 11.15%-231M | 17.20%-260M | 10.54%-314M | 1.96%-351M | 10.28%-358M | -100.00%-2M | 15.69%-129M | -11.11%-100M |
Net other fund-raising expenses | -4,562.50%-373M | 87.50%-8M | 61.21%-64M | 96.06%-165M | -1,968.75%-4.19B | 369.88%224M | 96.95%-83M | 95.24%-4M | 88.71%-7M | 98.02%-51M |
Financing cash flow | -112.30%-1.52B | 1,217.83%12.35B | 94.96%-1.11B | -4,472.65%-21.9B | 49.79%-479M | 82.30%-954M | 60.40%-5.39B | 213.12%3.11B | -92.23%-4.06B | 140.09%1.27B |
Net cash flow | ||||||||||
Beginning cash position | -0.03%40.7B | -12.18%40.71B | 23.28%46.36B | -5.91%37.61B | -15.70%39.97B | 15.59%47.41B | -4.97%41.02B | -4.78%39.15B | 0.90%39.54B | -18.58%34.44B |
Current changes in cash | 278.52%1.62B | 86.23%-908M | -174.02%-6.59B | 486.80%8.91B | 67.43%-2.3B | -227.07%-7.07B | 398.82%5.56B | 8,059.05%8.36B | -143.95%-483M | 252.69%4.4B |
Effect of exchange rate changes | 3.58%926M | -5.50%894M | 577.78%946M | 1.49%-198M | 46.11%-201M | -261.47%-373M | 182.50%231M | -3,366.67%-98M | -88.72%94M | 142.55%100M |
Cash adjustments other than cash changes | 3,100.00%32M | --1M | ---- | -68.57%44M | --140M | ---- | 60,100.00%600M | --1M | --0 | ---- |
End cash Position | 6.34%43.28B | -0.03%40.7B | -12.18%40.71B | 23.28%46.36B | -5.91%37.61B | -15.70%39.97B | 15.59%47.41B | 15.59%47.41B | -4.78%39.15B | 0.90%39.54B |
Free cash flow | 74.74%-3.36B | -128.04%-13.28B | -118.40%-5.82B | 603.00%31.64B | -34.34%-6.29B | -132.90%-4.68B | 43.48%14.23B | 5,236.46%5.12B | 7.49%4.21B | 2,108.63%5.12B |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |